The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia-Reference-Cited by-同舟云学术

The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia

Published:2011-06-29 Issue:17 Volume:12 Page:2605-2611
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Agouridis Aris P,Tsimihodimos Vasilis,Filippatos Theodosios D,Dimitriou Andromachi A,Tellis Costantinos C,Elisaf Moses S,Mikhailidis Dimitri P,Tselepis Alexandros D

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.2011.591383

Reference48 articles.

1. Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels

2. PAF-Degrading Acetylhydrolase Is Preferentially Associated With Dense LDL and VHDL-1 in Human Plasma

3. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase

4. Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

5. Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. La phospholipase A2 associée aux lipoprotéines (Lp-PLA2) : biomarqueur pertinent et cible thérapeutique ?;Annales Pharmaceutiques Françaises;2024-09

2. The effect of rosuvastatin alone or in combination with fenofibrate or omega-3 fatty acids on lipoprotein(a) levels in patients with mixed hyperlipidemia;Archives of Medical Science – Atherosclerotic Diseases;2024-02-16

3. Serum levels of sLOX‐1 and Lp‐PLA2 can predict the prognosis of acute cerebral infarction with a high specificity;Physiological Reports;2022-01

4. On the present and future role of Lp-PLA2 in atherosclerosis-related cardiovascular risk prediction and management;Archives of Medical Science;2021-07-16

5. Influence of lipid-lowering drugs on inflammation: what is yet to be done?;Archives of Medical Science;2021-03-20